293 related articles for article (PubMed ID: 32883537)
1. Data of Italian Cancer Centers from two regions with high incidence of SARS CoV-2 infection provide evidence for the successful management of patients with locally advanced and metastatic melanoma treated with immunotherapy in the era of COVID-19.
Pala L; Conforti F; Saponara M; De Pas T; Giugliano F; Omodeo Salè E; Jemos C; Rubatto M; Agostini A; Quaglino P; Fava P; Fierro MT; Queirolo P
Semin Oncol; 2020 Oct; 47(5):302-304. PubMed ID: 32883537
[TBL] [Abstract][Full Text] [Related]
2. Clinical and epidemiological characteristics associated with pneumonia at disease onset in patients admitted for COVID-19 to the Emergency Department of a large Hospital in Piedmont (North-Western Italy).
Sacerdote C; Castiglione A; Pagano E; Migliore E; Pivetta E; Auzzas GM; Brenstisci C; Brunetti F; Dafilé C; Gangemi M; Giacometti L; Gilardetti M; Martinis VH; Saccona F; Stura A; Turco D; Balestro C; Zozzoli S; Filandra U; Roggero S; Silvestre C; Scozzari G; Scaramozzino A; Ciccone G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):216-225. PubMed ID: 33412813
[TBL] [Abstract][Full Text] [Related]
3. Impact of COVID-19 outbreak on cancer immunotherapy in Italy: a survey of young oncologists.
Ottaviano M; Curvietto M; Rescigno P; Tortora M; Palmieri G; Giannarelli D; Aieta M; Assalone P; Attademo L; Avallone A; Bloise F; Bosso D; Borzillo V; Buono G; Calderoni G; Caputo F; Cartenì G; Cavallero D; Cavo A; Ciardiello F; Conca R; Conteduca V; De Falco S; De Felice M; De Laurentiis M; De Placido P; De Placido S; De Santo I; De Stefano A; Della Corte CM; Di Franco R; Di Lauro V; Fabbrocini A; Federico P; Festino L; Giordano P; Giuliano M; Gridelli C; Grimaldi AM; Lia M; Marretta AL; Massa V; Mennitto A; Merler S; Merz V; Messina C; Messina M; Milano M; Minisini AM; Montesarchio V; Morabito A; Morgillo F; Mucci B; Nappi L; Napolitano F; Paciolla I; Pagliuca M; Palmieri G; Parola S; Pepe S; Petrillo A; Piantedosi F; Piccin L; Picozzi F; Pietroluongo E; Pignata S; Prati V; Riccio V; Rosanova M; Rossi A; Russo A; Salati M; Santabarbara G; Sbrana A; Simeone E; Silvestri A; Spada M; Tarantino P; Taveggia P; Tomei F; Vincenzo T; Trapani D; Trojanello C; Vanella V; Vari S; Ventriglia J; Vitale MG; Vitiello F; Vivaldi C; von Arx C; Zacchi F; Zampiva I; Zivi A; Daniele B; Ascierto PA;
J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33060148
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 in cancer patients: clinical characteristics and outcome-an analysis of the LEOSS registry.
Rüthrich MM; Giessen-Jung C; Borgmann S; Classen AY; Dolff S; Grüner B; Hanses F; Isberner N; Köhler P; Lanznaster J; Merle U; Nadalin S; Piepel C; Schneider J; Schons M; Strauss R; Tometten L; Vehreschild JJ; von Lilienfeld-Toal M; Beutel G; Wille K;
Ann Hematol; 2021 Feb; 100(2):383-393. PubMed ID: 33159569
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 infections in the Friuli Venezia Giulia Region (Northern Italy): a population-based retrospective analysis.
Calagnan E; Gobbato M; Burba I; Del Zotto S; Toffolutti F; Serraino D; Tonutti G
Epidemiol Prev; 2020; 44(5-6 Suppl 2):323-329. PubMed ID: 33412825
[TBL] [Abstract][Full Text] [Related]
6. Impact of treatment delay due to the pandemic of COVID-19 on the efficacy of immunotherapy in head and neck cancer patients.
Chen G; Wu Q; Jiang H; Li Z; Hua X; Hu X; Yu H; Xie C; Zhong Y
J Hematol Oncol; 2020 Dec; 13(1):174. PubMed ID: 33308264
[TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Italian Pediatric Oncology Patients: A Study From the Infectious Diseases Working Group of the Associazione Italiana di Oncologia e Ematologia Pediatrica.
Bisogno G; Provenzi M; Zama D; Tondo A; Meazza C; Colombini A; Galaverna F; Compagno F; Carraro F; De Santis R; Meneghello L; Baretta V; Cesaro S
J Pediatric Infect Dis Soc; 2020 Nov; 9(5):530-534. PubMed ID: 32652521
[TBL] [Abstract][Full Text] [Related]
8. Patients with locally advanced and metastatic cutaneous squamous cell carcinoma treated with immunotherapy in the era of COVID-19: stop or go? Data from five Italian referral cancer centers.
Saponara M; Pala L; Conforti F; Rubatto M; De Risi I; Spagnolo F; Guida M; Bossi P; Quaglino P; Queirolo P
Ther Adv Med Oncol; 2020; 12():1758835920977002. PubMed ID: 33273966
[TBL] [Abstract][Full Text] [Related]
9. Early cases of SARS-CoV-2 infection in Uganda: epidemiology and lessons learned from risk-based testing approaches - March-April 2020.
Migisha R; Kwesiga B; Mirembe BB; Amanya G; Kabwama SN; Kadobera D; Bulage L; Nsereko G; Wadunde I; Tindyebwa T; Lubwama B; Kagirita AA; Kayiwa JT; Lutwama JJ; Boore AL; Harris JR; Bosa HK; Ario AR
Global Health; 2020 Nov; 16(1):114. PubMed ID: 33239041
[TBL] [Abstract][Full Text] [Related]
10. Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital.
Clementi N; Ferrarese R; Tonelli M; Amato V; Racca S; Locatelli M; Lippi G; Silvestri G; Clementi M; Mancini N
Clin Chem Lab Med; 2020 Aug; 58(9):1573-1577. PubMed ID: 32598306
[TBL] [Abstract][Full Text] [Related]
11. Do standards of care and early outcomes of periprosthetic fractures change during the COVID-19 pandemic? A multicentre study.
Zagra L; D'Apolito R; Guindani N; Zatti G; Rivera F; Ravasi F; Mosconi M; Momoli A; Massè A; Franceschini M; D'Angelo F; Dallari D; Catani F; Casiraghi A; Bove F; Castelli CC
J Orthop Traumatol; 2021 Jun; 22(1):22. PubMed ID: 34128114
[TBL] [Abstract][Full Text] [Related]
12. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.
Quaglino P; Fava P; Brizio M; Marra E; Rubatto M; Agostini A; Tonella L; Ribero S; Fierro MT
J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1395-1396. PubMed ID: 32426877
[No Abstract] [Full Text] [Related]
13. [Chronic diseases and risk of symptomatic COVID-19: results of a case-population study on a sample of patients in the Local Health Unit 'Toscana Centro' (Tuscany Region, Central Italy)].
Profili F; Ballo P; Balzi D; Bellini B; Bartalocci S; Zuppiroli A; Voller F; Francesconi P
Epidemiol Prev; 2020; 44(5-6 Suppl 2):308-314. PubMed ID: 33412823
[TBL] [Abstract][Full Text] [Related]
14. Inappropriate risk perception for SARS-CoV-2 infection among Italian HCWs in the eve of COVID-19 pandemic.
Riccò M; Vezzosi L; Balzarini F; Bragazzi NL
Acta Biomed; 2020 May; 91(3):e2020040. PubMed ID: 32921735
[TBL] [Abstract][Full Text] [Related]
15. COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: the COVINT study.
Nichetti F; Bini M; Ambrosini M; Ottini A; Rametta A; Leporati R; Polastri D; Pircher C; Dotti K; Ferrari L; de Braud F
ESMO Open; 2020 Nov; 5(Suppl 3):. PubMed ID: 33158968
[TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
Mandala M; Lorigan P; De Luca M; Bianchetti A; Merelli B; Bettini AC; Bonomi L; Nahm S; Vitale MG; Negrini G; Di Croce A; Ascierto PA; Rulli E; Tondini CA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33593827
[TBL] [Abstract][Full Text] [Related]
17. Impact of Covid-19 on the management of patients with metastatic melanoma.
Welti M; Cheng PF; Mangana J; Levesque MP; Dummer R; Imhof L
Oncotarget; 2022 Dec; 13():1370-1379. PubMed ID: 36580495
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of SARS-CoV-2 infection among symptomatic healthcare workers in a large university tertiary hospital in São Paulo, Brazil.
Buonafine CP; Paiatto BNM; Leal FB; de Matos SF; de Morais CO; Guerra GG; Martuchelli MVV; Oliveira DBL; Durigon EL; Soares CP; Candido ED; Telezynski BL; Sáfadi MAP; Almeida FJ
BMC Infect Dis; 2020 Dec; 20(1):917. PubMed ID: 33267836
[TBL] [Abstract][Full Text] [Related]
19. Course of Sars-CoV2 Infection in Patients with Cancer Treated with anti-PD-1: A Case Presentation and Review of the Literature.
Pala L; Conforti F; Cocorocchio E; Ferrucci P; De Pas MT; Stucchi S; Repetto M; Saponara M; Queirolo P
Cancer Invest; 2021 Jan; 39(1):9-14. PubMed ID: 33125301
[TBL] [Abstract][Full Text] [Related]
20. [Oncological organized screening programmes in the COVID-19 era: an Italian survey on accrued delays, reboot velocity, and diagnostic delay estimates].
Mantellini P; Battisti F; Armaroli P; Giubilato P; Ventura L; Zorzi M; Battagello J; Sassoli de Bianchi P; Senore C; Zappa M
Epidemiol Prev; 2020; 44(5-6 Suppl 2):344-352. PubMed ID: 33412828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
